Carl Zeiss Meditec
Almudena Sánchez Barthe has a strong background in finance and controlling, with a focus on achieving positive cash flow and optimizing financial processes. Almudena started their career in 1999 as a Finance Manager Assistant at HEFAGRA, where they gained experience in financial management. Almudena then worked as a Treasury Responsible at Unicaja in 2002 before moving on to Cable & Wireless in 2003 as a Financial Analyst, responsible for cash flow management and financial reporting. In 2004, they joined Draeger as a Controller, where they analyzed relevant data, implemented transparency projects, and developed business plans. In 2014, they joined ZEISS Medical Technology as a Business Controller, and later became the Finance Director, responsible for implementing effective credit policies, managing tax audits, and optimizing operational expenses. Almudena is currently serving as the Head of Finance Controlling and Operations, focusing on the design and implementation of financial management tools.
Almudena Sánchez Barthe completed a Directive Development Program (PDD) at IESE Business School in 2007. In 2002-2003, they obtained a Master of Business Administration (MBA) from IEDE. Earlier, they received a Licentiate degree in Business Administration and Management, General from Universidad de Granada in the period of 1996-2001. Lastly, Almudena completed an Executive Programm at Dealing with People from 2006 to 2011.
This person is not in any teams
This person is not in any offices
Carl Zeiss Meditec
8 followers
Carl Zeiss Meditec is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose and throat surgery, as well as the activities in the field of intraoperative radiation. The Company has various production sites in Europe, the United States and Asia.